Capital Markets

A new partnership integrates CME's premier FX venues into FlexTrade's platform, promising traders deeper liquidity and unprecedented market transparency.

Cantor Fitzgerald launches its 15th SPAC, raising $115M. With the market rebounding, will this bet on tech and healthcare pay off for investors?

DraftKings partners with Crypto.com to launch player-specific sports contracts and eyes political markets, navigating a complex federal regulatory landscape.

Fintech firm SOLOWIN HOLDINGS partners with Alibaba's Taobao Shangou to launch a blockchain-powered system that rewards consumers for low-carbon choices.

The veteran SPAC sponsor closes an upsized IPO for its eighth fund, targeting industrial tech and energy transition with a unique warrant-free structure.

Pan-European exchange reports a strong start to 2026, fueled by a historic defense IPO and a dramatic spike in foreign exchange and metals trading.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?

A new bond issue strengthens Agilyx's finances, funding a dual strategy focused on immediate earnings and long-term tech licensing in plastic recycling.

Nodal Exchange's record January highlights booming demand for energy and carbon derivatives as the green transition accelerates market volatility and risk.

Upexi's new funding bolsters its ambitious Solana treasury, but the deal's terms, including warrant adjustments, raise dilution concerns for investors.

Crypto exchange Phemex now offers 24/7 stock and metal futures, a bold move to unify markets that also navigates a complex and risky regulatory maze.

Marex's acquisition of Webb Traders signals a major push into automated equity derivatives, aiming to internalize hedging and challenge market norms.

Industrial conglomerate Schouw & Co. offers a fee for bondholder consent to spin off its aquaculture giant BioMar, a move that could unlock value but alters risk.

Mawson Infrastructure reports a steep Q4 revenue drop but a smaller annual loss, clearing major legal hurdles to focus on its AI and green energy future.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

Stablecoin giant Tether's $150M investment in Gold.com signals a new era, merging physical gold with blockchain to redefine asset ownership.

As Churchill Capital XI's shares and warrants begin separate trading, what does this mean for investors and the hunt for Michael Klein's next big deal?

After a blockbuster IPO raised nearly $300 million, dermatologist-founded Veradermics is poised to challenge the hair loss market with its new oral pill.

Veteran investor Stephen Riddell partners with Gallatin Point to launch DS2 Capital, a new firm poised to navigate the complex structured credit market.

Colombier Acquisition Corp. III, with a board of political and tech heavyweights, has a $299M war chest. Its hunt for a 'patriotic' target begins.